Non-small cell lung cancer (NSCLC)
RAINFOL-03 (GCT1184-03)
Phase III Study to assess the efficacy and safety of ADC compared to treatment of investigator’s choice in participants with endometrial cancer
Trial overview
Clinical Area
Medical Oncology
Disease
Non-small cell lung cancer (NSCLC)
Disease site
Lung & bronchus
Study Phase
II
Trial Identifiers
Registration number: NCT07288177
Principal Investigator(s)
··
··